CAS: 5131-24-8; Ditalimfos

上下游产品

CAS号85-44-9 苯酐 | CAS号17321-48-1 Phosphoramidoth... | CAS号1074-82-4 邻苯二甲酰亚胺钾盐 | CAS号82873-34-5 N-Phthalimidoph... | CAS号598-02-7 磷酸二乙酯 | CAS号762-04-9 亚磷酸二乙酯 | CAS号2986-20-1 ethyl carbamimi... | CAS号5857-62-5 1-[2-(2-chlorop...

📜Dichlorophthalimidophosphine置于1,2,3,4,5,6,7,8-八硫杂环辛烷,三乙胺体系中,用 苯 作为反应溶剂,化学反应 4.0H,反应生成 灭菌磷
参考文献:Shaikhiev; Fridland; Mukhutdinova,Russian Journal Of General Chemistry,1999,Vol. 69,# 4,P. 557-559
标题:Shaikhiev; Fridland; Mukhutdinova,Russian Journal Of General Chemistry,1999,Vol. 69,# 4,P. 557-559

专利信息

专利号:US-11912654-B2
优先权日:2021-09-03
标 题:Process for stereospecific synthesis of vitamin K2 and its novel intermediates
发明人：MEHTA DILIP; SHASHTRI MAYANK; RAJU BNS; SHAH ASHWIN; VORA PARIN; MAHALE UMAKANT
权利人:SYNERGIA LIFE SCIENCES PVT LTD
摘要:The present disclosure relates to a novel process for the synthesis of stereospecific compounds of Vitamin K2 group in general and Vitamin K2-7. The present disclosure further discloses novel intermediates useful in the synthesis of stereospecific Vitamin K2-7. Compounds of the Vitamin K2 group obtained are crystalline and exhibit well defined melting points.

专利号:WO-2023031841-A1
优先权日:2021-09-03
标题:A process for the stereospecific synthesis of vitamin k2 and its intermediates
发明人：MEHTA DILIP; SHASHTRI MAYANK; RAJU BNS; VORA PARIN; MAHALE UMAKANT
权利人:SYNERGIA LIFE SCIENCES PVT LTD
摘要:The present disclosure relates to a novel process for the synthesis of stereospecific compounds of Vitamin K2 group in general and Vitamin K2-7, in particular. It also discloses novel intermediates useful in the synthesis of stereospecific Vitamin K2-7. Compounds of the Vitamin K2 group obtained are crystalline and exhibit well defined melting points.

专利号:WO-2025056767-A1
优先权日:2023-09-15
标题 :Process for the preparation of enantiomerically enriched aliphatic amines
发明人：BOU HAMDAN FARHAN; GODINEAU EDOUARD; SMEJKAL TOMAS; DUMEUNIER RAPHAEL; BOUSSEMGHOUNE MOHAMED ABDELOUAHAB; BLUM MATHIAS
权利人:SYNGENTA CROP PROTECTION AG
摘要:The present invention relates to a process for the preparation of enantiomerically enriched cyclobutylamines of formula (I) from α-tertiary cyclobutanones and reacting said enantiomerically enriched cyclobutylamines to enantiomerically enriched cyclobutylamides. Such compounds are useful intermediates in the synthesis of microbiocidal thiazole compounds.

专利号:US-9592205-B2
优先权日:2011-09-21
标 题 :Fascile synthesis of biocompatible polymer capsule nanoparticles for drug encapsulation
发明人：SHIEH DAR-BIN
权利人:SHIEH DAR-BIN; UNIV NAT CHENG KUNG
摘要:The present invention relates to a method for preparing a capsule nanoparticle used in encapsulating hydrophobic medicines, comprising the following steps: (A) providing a biocompatible polymer and an organic solution containing a hydrophobic medicine; (B) stirring the organic solution at 3-10° C., and titrating with an alcohol solution, so as to make the biocompatible polymer encapsulate hydrophobic medicine to form a capsule nanoparticle; (C) ultrasonic vibrating the capsule nanoparticle at 3-10° C.; (D) filtering the capsule nanoparticle to an average size controllable in the range of 60-450 nm; and (E) lyophilizing the encapsulated particles.

专利号:US-11584772-B2
优先权日:2017-09-12
标 题 :N4-modified cytidine nucleotides and their use
发明人：MESKYS ROLANDAS; JAKUBOVSKA JEVGENIJA; TAURAITE DAIVA
权利人:UNIV VILNIUS
摘要:Disclosed are W-position modified cytidine nucleotides of formula (I). Provided herein are methods of chemical synthesis of AP-modified cytidine nucleoside triphosphates and their applications as well as uses of the cytidine analogues for the synthesis of modified nucleic acids. The nucleic acid molecule includes DNA, RNA or a combination of DNA/RNA. One of many applications of modified cytidine nucleotides described herein is enzyme selection, when an enzyme of interest bears an activity of an esterase, amidase, oxidoreductase, lyase, ligase or other enzymatic activity, formula (I) wherein the substituants are as defined in the appended claims.

专利号:US-2023093176-A1
优先权日:2021-09-03
标 题:Process for stereospecific synthesis of vitamin k2 and its novel intermediates